Established in Ankleshwar in the year 1996, “Tatva Chintan Pharma Chem Pvt Ltd” is noted as a notable manufacturer and supplier of a broad assortment of hydroxides, specialty chemicals, methylating agents, electrolyte chemicals, pyridinium salts and many more. Tatva Chintan Pharma Chem IPO is open from 16 July 2021. They are a private limited firm, acting as a leading organization in this domain since its inception. These chemicals are processed using superior quality compounds and the latest technology under the direction of experienced chemical experts. The chemicals offered are highly demanding for their characteristics such as longer shelf life, precise formulation, moisture-proof packaging, etc. They offer these chemicals in several packaging options to meet the exact needs of their reputed clients. Due to their ethical business policies, client-oriented approach and competitive pricing structure; they are continuously expanding their market share.

Objects of the Issue:

• Funding capital expenditures requirements for expansion of Dahej manufacturing facility.
• Funding capital expenditures requirements to upgrade R&D facilities in Vadodara.
• To meet common corporate objectives

Company Financials:

Summary of financial Information (Restated Consolidated)

Tatva Chintan Pharma IPO Details

Tentative Timetable

The Tatva Chintan Pharma IPO open date is Jul 16, 2021, and the close date is Jul 20, 2021. The issue may list on Jul 28, 2021.

Lot Size

The Tatva Chintan Pharma IPO market lot size is 13 shares. A retail-individual investor can apply for up to 14 lots (182 shares or ₹197,106).

Promoter Holding

Pre-Issue Share Holding - 100%
Post-Issue Share Holding - 79.17%